Skip to main content
SpringerLink
Log in

Hypotensive effect of oxprenolol in mild to moderate hypertension: a multicentre controlled study

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

In a multicentre, double-blind, between-patient study the hypotensive effect of oxprenolol was investigated in 329 patients with mild to moderate hypertension. A factorial experimental design with three factors was chosen: oxprenolol — none or daily doses of 20, 40, 60 and 80 mg; dihydralazine and hydrochlorothiazide, respectively, none or 30 mg daily. Each treatment was given for 4 weeks after an adequate period of withdrawal from any other possible hypotensive therapy and one week of placebo wash-out. Irrespective of the association with dihydralazine and/or hydrochlorothiazide, oxprenolol had a hypotensive effect linearly related to dose for standing systolic (P<0.05) and diastolic (P<0.01) pressure, and for lying diastolic (P<0.05) pressure. The addition of dihydralazine enhanced the time-course of the hypotensive effect of oxprenolol, particularly the 80 mg dose level. In general, the combination of oxprenolol with dihydralazine and hydrochlorothiazide caused larger reductions in blood pressure, particularly with oxprenolol 80 mg. In the latter group, the eventual falls in blood pressure were 30.5 and 14.4 mmHg for lying systolic and diastolic, respectively; and 32.1 and 20.0 mmHg for the standing systolic and diastolic pressures. The drug was well tolerated; major side effects (heart failure and bronchospasm) occurred in three patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Prichard, B.N.C., Gillam, P.M.S.: Use of propranolol (Inderal) in treatment of hypertension. Brit. med. J.1964 II, 725

    Google Scholar 

  2. Tewari, S.N., Grant, R.H.E.: Propranolol in hypertension. Postgrad. med. J.44, 509 (1968)

    Google Scholar 

  3. Prichard, B.N.C.: Treatment of hypertension with propranolol. Brit. med. J.1969 I, 7

    Google Scholar 

  4. Zacharias, F.J., Cowen, K.J.: Controlled trial of propranolol in hypertension. Brit. med. J.1970 I, 471

    Google Scholar 

  5. Hansson, L., Malmcrona, R., Olander, R., Rosenhall, L., Westerlund A., Aberg, H., Hood, B.: Propranolol in hypertension — report on 158 patients treated up to one year. Klin. Wschr.50, 364 (1972)

    Google Scholar 

  6. Zacharias, F.J., Cowen, K.J., Prestt, J., Vickers, J., Wall, B.G.: Propranolol in hypertension: A study of long-term therapy, 1964 – 1970. Amer. Heart J.83, 755 (1972)

    Google Scholar 

  7. Hansson, L.: Beta-adrenergic blockade in essential hypertension. Acta med. scand. (Suppl.) 550 (1973)

  8. Paterson, J.W., Dollery, C.T.: Effect of propranolol in mild hypertension. Lancet 1966 II, 1148

    Google Scholar 

  9. Richards, F.A.: Propranolol in hypertension. Amer. J. Cardiol.18, 384 (1966)

    Google Scholar 

  10. Waal, H.J.: Hypotensive action of propranolol. Clin. Pharmacol. Ther.7, 588 (1966)

    Google Scholar 

  11. Dorph, S., Binder, C.: Evaluation of the hypotensive effect of beta-adrenergic blockade in hypertension. Acta med. scand.185, 443 (1969)

    Google Scholar 

  12. Eisalo, A., Loumanmaki, K., Heikkila, J.: Haemodynamic effects of TrasicorR, a new beta-adrenergic blocking agent, in hypertensive patients. Acta med. scand.186, 105 (1969)

    Google Scholar 

  13. Ambrosioni, E., Maresta, A., Magnani, B.: Efficacia anti-ipertensiva della somministrazione cronica per via orale del propranolol. Boll. Soc. ital. Cardiol.15, 620 (1970)

    Google Scholar 

  14. Leishman, A.W.D., Thirkettle, J.L., Allen, B.R., Dixon, R.A.: Controlled trial of oxprenolol and practolol in hypertension. Brit. med. J.1970 IV, 342

    Google Scholar 

  15. Bengtsson, C.: Comparison between alprenolol and chlorthalidone as antihypertensive agents. Acta med. scand.191, 433 (1972)

    Google Scholar 

  16. Gysling, E., Regoli, D.: Oxprenolol: long-term effects in arterial hypertension. Clin. Pharmacol. Ther.14, 995 (1973)

    Google Scholar 

  17. Humphreys, G.S., Delvin, D.G.: Ineffectiveness of propranolol in hypertensive Jamaicans. Brit. med. J.1968 II, 601

    Google Scholar 

  18. Richardson, D.W., Freund, J., Gear, A.S., Mauck, H.P., Preston L.W.: Effect of propranolol on elevated arterial blood pressure. Circulation37, 534 (1968)

    Google Scholar 

  19. Tuckman, J., Martin, R., Hodler, J.: Hypertoniebehandlung mit hohen Dosen von Oxprenolol, allein oder in Kombination mit dem Vasodilatator Dihydralazin. Helv. med. Acta36, 243 (1971)

    Google Scholar 

  20. Dahr, A.S.: Use of hydralazine and selctive cardiac adrenergic blockade in therapy of essential hypertension. Circulation46, 4, Suppl. II, 142 (1972)

    Google Scholar 

  21. Sannerstedt, R., Stenberg, J., Vedin, A., Wilhelmsson, C., Werko L.: Chronic beta adrenergic blockade in arterial hypertension — Hemodynamic influences of dihydralazine and dynamic exercise and clinical effects of combined treatment. Amer. J. Cardiol.29, 718 (1972)

    Google Scholar 

  22. Booker, W.M., West, W.L., Hyde, A.J., May-Cole, M.: Alteration of the carotid sinus reflex response by propranolol and by alpha methyldopa (abstract). Circulation39–40 (Suppl.3), 48 (1969)

    Google Scholar 

  23. Dunlop, D., Shanks, R.G.: Inhibition of the carotid sinus reflex by the chronic administration of propranolol. Brit. J. Pharmacol.36, 132 (1969)

    Google Scholar 

  24. Sleight, P., Gribbin, B., Pickering, T.G.: Baroreflex sensitivity in normal and hypertensive man: the effect of beta-adrenergic blockade on reflex sensitivity. Postgrad. med. J.47, (suppl. 79), (1971)

  25. Gill, D.G.: Adrenergic blockade in hypertension. Lancet 1972,I, 1125

    Google Scholar 

  26. Fröhlich, E.D., Tarazi, R.C., Dustan, H.P., Page, I.H.: The paradox of beta-adrenergic blockade in hypertension. Circulation37, 417 (1968)

    Google Scholar 

  27. Wilson, D.F., Watson, O.F., Peel, J.S., Langley, R.B., Turner, A.S.: Some haemodynamic effects of Trasicor (Ciba 39'989-Ba). N. Z. med. J.68, 145 (1968)

    Google Scholar 

  28. Branzi, A., Sanguinetti, M., Ambrosioni, E., Magnani, B.: Modificazioni indotte dalla somministrazione acuta e prolungata di propranololo sull'emodinamica sistemica negli ipertesi. Boll. Soc. ital. Cardiol.15, 627 (1970)

    Google Scholar 

  29. Tarazi, R.C., Fröhlich, E.D., Dustan, H.P.: Plasma volume changes with long-term beta-adrenergic blockade. Amer. Heart J.82, 770 (1971)

    Google Scholar 

  30. Lydtin, H., Kusus, T., Daniel, W., Schierl, W., Ackenheil, M., Kempter, H., Lohmoller, G., Niklas, M., Walter, I.: Propranolol therapy in essential hypertension. Amer. Heart J.83, 589 (1972)

    Google Scholar 

  31. Tarazi, R.C., Dustan, H.P.: Beta-adrenergic blockade in hypertension — Practical and theoretical implications of long-term hemodynamic variations. Amer. J. Cardiol.29, 632 (1972)

    Google Scholar 

  32. Franciosa, J.A., Freis, E.D., Conway, J.: Antihypertensive and hemodynamic properties of the new beta adrenergic blocking agent timolol. Circulation48, 118 (1973)

    Google Scholar 

  33. Shinebourne, E., Fleming, J., Hamer, J.: Effects of beta-adrenergic blockade during exercise in hypertensive and ischaemic heart-disease. Lancet 1967II, 1217

    Google Scholar 

  34. Majid, P.A., Sharma, B., Saxton, C., Stoker, J.B., Taylor, S.H.: Hemodynamic effects of oxprenolol in hypertensive patients. Postgrad. med. J.46 (Nov. Suppl.) 67 (1970)

    Google Scholar 

  35. Prichard, B.N.C., Shinebourne, E., Fleming, J., Hamer, J.: Haemodynamic studies in hypertensive patients treated by oral propranolol. Brit. Heart J.32, 236 (1970)

    Google Scholar 

  36. Lund-Johansen, P.: Hemodynamic changes at rest and during exercise in long-term beta-blocker therapy of essential hypertension. Acta med. scand.195, 117 (1974)

    Google Scholar 

  37. Michelakis, A.M., McAllister, R.G.: The effect of chronic adrenergic receptor blockade on plasma renin activity in man. J. clin. Endocr.34, 386 (1972)

    Google Scholar 

  38. Bühler, F.R., Laragh, J.H., Baer, L., Vaughan, D.E., Brunner, H.R.: Propranolol inhibition of renin secretion. New Engl. J. Med.287, 1209 (1972)

    Google Scholar 

  39. Castenfors, J., Johnsson, H., Orö, L.: Effect of alprenolol on blood pressure and plasma renin activity in hypertensive patients. Acta med. scand.193, 189 (1973)

    Google Scholar 

  40. Bühler, F.R., Laragh, J.H., Vaughan, D.E., Brunner, H.R., Gavras, H., Baer, L.: Antihypertensive action of propranolol. Amer. J. Cardiol.32, 511 (1973)

    Google Scholar 

  41. Day, M.D., Roach, A.G.: Beta-adrenergic receptors in the central nervous system of the cat concerned with control of arterial blood pressure and heart rate. Nature242, 30 (1973)

    Google Scholar 

  42. Dollery, C.T., Lewis, P.J., Myers, M.G., Reid, J.L.: Central hypotensive effect of propranolol in the rabbit. (abstract) Brit. J. Pharmacol.48, 343P (1973)

  43. Srivastava, R.K., Kulshrestha, V.K., Singh, N., Bhargava, K.P.: Central cardiovascular effects of intracerebroventricular propranolol. Europ. J. Pharmacol.21, 222 (1973)

    Google Scholar 

  44. Åblad, B.: A study of the mechanism of the haemodynamic effects of hydralazine in man. Acta pharmacol. (Kbh.)20 Suppl.1, 1 (1963)

    Google Scholar 

  45. Sannerstedt, R., Stenberg, J., Johnsson, G., Werkö, L.: Hemodynamic interference of alprenolol with dihydralazine in normal and hypertensive man. Amer. J. Cardiol.28, 316 (1971)

    Google Scholar 

  46. Brunner, H., Hedwall, P.R., Meier, M.: Influence of adrenergic beta-receptor blockade on the acute cardiovascular effects of hydralazine. Brit. J. Pharmacol.30, 123 (1967)

    Google Scholar 

  47. Brunner, H., Hedwall, P.R., Maier, R., Meier, M.: Pharmacological aspects of oxprenolol. Postgrad. med. J.46, No. Suppl, 5 (1970)

    Google Scholar 

  48. Dahr, A.S., George, C.F., Dollery, C.T.: The effect of selective cardiac adrenergic beta-blockade on the hypotensive effect of hydrallazine. Experientia (Basel)27, 545 (1971)

    Google Scholar 

  49. Scriabine, A., Ludden, C.T., Watson, L.S., Riley, R.L.: Enhancement of the antihypertensive action of hydralazine by MT, a beta-adrenergic blocking agent, in spontaneously hypertensive (SH) rats. Fed. Proc.31, 564 (abs.) (1972)

    Google Scholar 

  50. Campus, S., Rappelli, A., Fabris, F., Mathis, I.: Effetti della 1-4-diidrazinoftalazina sulla pressione arteriosa e sulla frequenza cardiaca, prima e dopo somministrazione di farmaci beta-bloccanti. Boll. Soc. ital. Biol. sper.43, 1847 (1967)

    Google Scholar 

  51. Katila, M., Frick, M.H.: Combined dihydralazine and propranolol in the treatment of hypertension. Int. J. clin. Pharmacol.1, 111 (1970)

    Google Scholar 

  52. Suzman, M.M.: The control of hypertension by a combination of hydralazine and propranolol or practolol. Cardiovasc. Res. VIth World Congr. Cardiol. p. 301, 1970

  53. Berglund, G., Hansson, L.: The treatment of hypertension with propranolol and hydralazine. Läkartidningen68, 5009 (1971)

    Google Scholar 

  54. Hansson, L., Olander, R., Aberg, H., Malmcrona, R., Westerlund, A.: Treatment of hypertension with propranolol and hydralazine. Acta med. scand.190, 531 (1971)

    Google Scholar 

  55. Vedin, A., Werkö, L., Wilhelmsson, C.: The treatment of hypertension with alprenolol and hydralazine. Läkartidningen68, 5005 (1971)

    Google Scholar 

  56. Aenishänslin, W., Pestalozzi-Kerpel, J., Dubach, U.C., Imhof, P.R., Turri, M.: Antihypertensive therapy with adrenergic beta-receptor blockers and vasodilators. Europ. J. clin. Pharmacol.4, 177 (1972)

    Google Scholar 

  57. Zacest, R., Gilmore, E., Koch-Weser, J.: Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade. New Engl. J. Med.286, 617 (1972)

    Google Scholar 

  58. Zacest, R., Koch-Weser, J.: Relation of hydralazine plasma concentration to dosage and hypotensive action. Clin. Pharmacol. Ther.13, 420 (1972)

    Google Scholar 

  59. Pape, J.: The effect of alprenolol in combination with hydralazine in essential hypertension. Acta med. scand. Suppl. 554, 55 (1974)

    Google Scholar 

  60. Tobian, L.: Why do thiazide diuretics lower pressure in essential hypertension? Ann. Rev. Pharmacol.7, 399 (1967)

    Google Scholar 

  61. Pohl, J.E.F., Thurston, H., Swales, J.D.: The antidiuretic action of diazoxide. Clin.Sci.42, 145 (1972)

    Google Scholar 

  62. Humphrey, S.J., Williams, J.E., Zins, G.R.: Renal tubular site of enhanced sodium reabsorption in dogs treated with direct peripheral vasodilators (abstract). Fed. Proc.30, 607 (1971)

    Google Scholar 

  63. Gilmore, E., Weil, J., Chidsey, C.: Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade. New Engl. J. Med.282, 521 (1970)

    Google Scholar 

  64. Scheffé, H.: The analysis of variance. New York: J. Wiley and Sons, 1959

    Google Scholar 

  65. Simpson, F.O., Waal-Manning, H.J.: Hypertension and beta-adrenergic blockade. Symposium: Beta adrenergic blocking agents, p. 59, Sydney, Australia, 23.2.1970 — Basle: Sandoz 1970

    Google Scholar 

  66. Seedat, Y.K., Reddy, J.: Propranolol in the South African non-white hypertensive patients. S. Afr. med. J.45, 284 (1971)

    Google Scholar 

  67. Morgan, T.O., Louis, W.J., Dawborn, J.K., Doyle, A.E.: The use of pindolol (Visken) in the treatment of hypertension. Med. J. Aust.2, 309 (1972)

    Google Scholar 

  68. O'Brien, E., McKinnon, J.: Propranolol and polythiazide in treatment of hypertension. Brit. Heart J.34, 1042 (1972)

    Google Scholar 

  69. Lambert, D.M.D.: The use of propranolol in the treatment of hypertension. Practitioner210, 277 (1973)

    Google Scholar 

  70. Seedat, Y.K., Stewart-Wynne, E.G., Reddy, J., Randeree, M.: Experiences with beta-adrenergic blockade drugs in hypertension. S. Afr. med. J.47, 259 (1973)

    Google Scholar 

  71. Fröhlich, E.D., Tarazi, R.C., Dustan, H.P.: Beta-adrenergic blocking therapy in hypertension: selection of patients. Int. J. Clin. Pharmacol.1, 151 (1970)

    Google Scholar 

  72. Gottlieb, T.B., Katz, F.H., Chidsey, C.A.: Combined therapy with vasodilator drugs and beta-adrenergic blockade in hypertension. A comparative study of Minoxidil and hydralazine. Circulation45, 571 (1972)

    Google Scholar 

  73. Collins, I.S., King, I.W.: Pindolol (Visken), LB46), a new treatment for hypertension: report of a multicentric open study. Curr. ther. Res.14, 185 (1972)

    Google Scholar 

  74. Angervall, G., Bystedt, U.: The effect of alprenolol in combination with saluretics in hypertension. Acta med. scand. Suppl. 554, 39 (1974)

    Google Scholar 

  75. Tibblin, G., Ablad, B.: Antihypertensive therapy with alprenolol, a beta-adrenergic receptor antagonist. Acta med. scand.186 451 (1969)

    Google Scholar 

  76. Prichard, B.N.C.: Propranolol as an antihypertensive agent. Amer. Heart J.79 128 (1970)

    Google Scholar 

  77. Esler, M.D., Nestel, P.J.: Evaluation of practolol in hypertension — Effects on sympathetic nervous system and renin responsiveness. Brit. Heart J.35 469 (1973)

    Google Scholar 

  78. Tewari, S.N.: Propranolol in hypertension. Brit. med. J.3 313 (1968)

    Google Scholar 

  79. Furberg, C., Michaelson, G.: Effect of Aptin, a beta-adrenergic blocking agent, in arterial hypertension. Acta med. scand.186 447 (1969)

    Google Scholar 

  80. Comerford, M. B., Pringle, A.: A long-term study of the antihypertensive effect of alprenolol. Acta med. scand. Suppl. 554, 15 (1974)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Research Department, CIBA-GEIGY, Milan, Italy

    M. Motolese, G. Muiesan & A. Colombi

  2. Semeiotica Medica, University of Perugia, Italy

    M. Motolese, G. Muiesan & A. Colombi

  3. Servizio Studi e Ricerche Cliniche, CIBA-GEIGY, Viale di Villa Massimo 29, I - 00161, Roma, Italy

    M. Motolese

Authors
  1. M. Motolese
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Muiesan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Colombi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Motolese, M., Muiesan, G. & Colombi, A. Hypotensive effect of oxprenolol in mild to moderate hypertension: a multicentre controlled study. Eur J Clin Pharmacol 8, 21–31 (1975). https://doi.org/10.1007/BF00616411

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00616411

Key words

Search

Navigation